Introduction {#s1}
============

Pectin, a galacturonic acid-rich complex polysaccharide found in all plant cell walls (CWs), is composed of homogalacturonan (HG), xylogalacturonan, apiogalacturonan, rhamnogalacturonan I, and rhamnogalacturonan II ([@CIT0079]). HG, a linear homopolymer of α-1,4-linked [d]{.smallcaps}-galactopyranosyluronic acid with varying extents of methylation and acetylation, is the most abundant component ([@CIT0054]). Phytopathogens are known to produce endo*-* and exo-polygalacturonases (PGs) that can breakdown HG ([@CIT0078]). As a counter stratagem, plants employ polygalacturonase-inhibitor proteins (PGIPs) to modulate PG activity leading to an accumulation of elicitor-active oligogalacturonides ([@CIT0015]). PGIPs are CW-bound glycoproteins belonging to the extracyoplasmic leucine-rich repeat (LRR) family of proteins ([@CIT0067]). PGIPs are very diverse in their PG-inhibition specificity and potential with varying degrees of inhibition ([@CIT0030]).

PG--PGIP complexes are considered a model protein--protein interaction system in the backdrop of plant--pathogen interactions ([@CIT0053]). Although three-dimensional structures of many PGs have been elucidated to date ([@CIT0060]; [@CIT0026]; [@CIT0008]), the only PGIP whose crystal structure has been solved is that of *Pv*PGIP2 from *Phaseolus vulgaris* ([@CIT0018]). Most of the data available on the PG--PGIP interactions has been a result of studies involving *Pv*PGIP2. Previous studies employed targeted mutation of *pg* and *pgip* genes, and investigated the *in vitro* inhibition behaviour of the protein variants synthesized to identify the amino acid residues involved in the protein--protein interactions ([@CIT0043]; [@CIT0051]; [@CIT0061]). Amide-exchange mass spectrometry in combination with protease protection and fluorescence spectrometric analysis was employed to deduce the amino acids of *An*PGII, a PG isoform II from *Aspergillus niger*, required for interaction with *Pv*PGIP2 ([@CIT0039]). The availability of advanced bioinformatic tools for protein homology modelling and docking have been exploited in in-depth analysis of PG--PGIP complexes *in silico* and found to be in conformity with the experimental results ([@CIT0045]; [@CIT0052]).

In contrast to the magnitude of literature available on dicot PGIPs, information available in case of monocots is meagre. Although PGIPs from wheat and rice have been tested for inhibition against various PGs ([@CIT0033]; [@CIT0036]; [@CIT0035], [@CIT0034]), no efforts have gone into understanding their mode of inhibition and the underlying structural basis of their interaction with PGs. In addition, no attempt has been made towards characterization of PGIPs from millets, small-grained gramineous monocots. Pearl millet \[*Pennisetum glaucum* (L.) R. Br.; synonym: *Cenchrus americanus* (L.) Morrone\], is among the most important cereal crops grown in the semi-arid tropical regions of Africa and the Indian subcontinent ([@CIT0065]).

In the present study, the gene encoding pearl millet PGIP was isolated and expressed heterologously as a maltose-binding protein (MBP) fusion in *Escherichia coli*. The purified recombinant fusion protein was employed in *in vitro* inhibition studies against two fungal PGs, *An*PGII and *Fm*PGIII (PG isoform III from *Fusarium moniliforme* isolate PD). *Pv*PGIP2, the most wide-spectrum and potent inhibitor of fungal PGs ([@CIT0023]), has been shown to inhibit *An*PGII ([@CIT0072]) and is reported to be ineffective against *Fm*PGIII ([@CIT0066]). A study of the inhibition profile of pearl millet PGIP against the same two PGs was carried out to elucidate the relationship between the extent of sequence similarity and the corresponding ability to inhibit PG. Furthermore, in the present study, *in silico* protein modelling, docking, and mutation analyses were carried out to explain the *in vitro* results, gain an understanding of the underlying structural basis of interaction, and predict the putative amino acids involved. To the best of our knowledge, this is the first report on the production of recombinant PGIP from millets and exploration of its inhibitory potential.

Materials and methods {#s2}
=====================

Plant material {#s3}
--------------

Seeds of pearl millet (*P. glaucum*) cultivar IP18296, obtained from the International Crops Research Institute for the Semi-Arid Tropics, Hyderabad, India, were used in this study. The seeds were germinated on moist germination sheets; 2-d-old seedlings were harvested and stored at --80 °C till further use.

Isolation of nucleic acids {#s4}
--------------------------

Total RNA and genomic DNA were extracted from 2-d-old pearl millet coleoptiles using a Total Plant RNA Isolation kit (Sigma) and a GeneJET™ Plant Genomic DNA Purification Mini kit (Thermo Scientific), respectively, as per the manufacturer's instructions.

*Isolation and cloning of partial* pgip *genes* {#s5}
-----------------------------------------------

The cDNA was prepared by means of a two-step AMV RT-PCR kit (Qiagen) as per the manufacturer's instructions, using total RNA from pearl millet coleoptiles as template. For PCR amplification of the partial *pgip* genes, primers Par1For (5ʹ-CTCGACCTCTCCTTCAACTC-3ʹ)/Par1Rev (5ʹ-ATGCCGCC GTAGATGGCGTT GTG-3ʹ) and Par2For (5ʹ-TGCGACTGGTA CGACGTCGACTG-3ʹ)/ Par2Rev (5ʹ-TCGCCACCTGCGCCGGG ATG-3ʹ) were designed based on the consensus region obtained by alignment of known monocot *pgip* gene sequences (GenBank accession nos AM180652--AM180657, NP_001147231, and XP_002439099) (Clone Manager Professional 9, Sci-Ed software). The amplification using *Taq* DNA polymerase (Merck Biosciences) resulted in \~400bp (*Pglpgip1p*) and \~500bp (*Pglpgip2p*) bands, respectively. They were gel purified using a QIAquick Gel Extraction kit (Qiagen), cloned in pTZ57R/T (InsTA clone PCR Cloning kit; Fermentas), and sequenced at Eurofins MWG Operon, Germany. Nucleotide BLAST (<http://blast.ncbi.nlm.nih.gov/Blast.cgi>) searches were performed using default parameters to ascertain the gene identity.

Southern blot analysis {#s6}
----------------------

Pearl millet genomic DNA (10 µg) was digested with restriction endonucleases separately: *Apo*I (New England Biolabs, Germany), *Ahd*I, *Bam*HI, *Eco*RI, *Hin*dIII, *Kpn*I, *Msc*I, *Nae*I, *Sac*I, *Xba*I, and *Xho*I (Thermo Scientific) and separated electrophoretically on a 0.7% agarose gel as described by [@CIT0063]. The DNA was transferred to a positively charged nylon membrane (Roche) as per the manufacturer's instructions. As a hybridization probe, PCR-amplified *Pglpgip1p* was random-prime labelled using a DIG High Prime DNA Labeling and Detection Starter kit II (Roche). Pre-hybridization, hybridization, and chemiluminescent detection were performed as described previously ([@CIT0080]). Hybridization was carried out at 63 °C.

Inverse PCR {#s7}
-----------

Pearl millet genomic DNA (3 µg) was digested using *Apo*I (New England Biolabs) and the digest mix was cleaned up using a NucleoSpin^®^ Gel and PCR Clean-up kit (Macherey-Nagel). A 500ng aliquot of the cleaned-up digest was self-ligated using a Rapid DNA Ligation kit (Thermo Scientific).

The following two sets of inverse PCR primers, Inv1A (5ʹ-AC GCCTTCAGCTTCAACCTCTC-3ʹ)/Inv1B (5ʹ-TTGTGCGACA GCACTAGGGATG-3ʹ) and Inv2A (5ʹ-AGAGGTAGATCTGGT CGGCG-3ʹ)/Inv2B (5ʹ-CGCCAATTTCGCGCACC-3ʹ) were designed based on the *Pglpgip1p* and *Pglpgip2p* sequences, respectively. The PCR was carried out using Phusion^®^ Hot Start High-Fidelity DNA polymerase (Finnzymes) with 30ng of self-ligated DNA as template. To the blunt-end PCR product of \~2kb obtained with Inv1A/Inv1B, an 'A' overhang was attached using *Taq* DNA polymerase (Thermo Scientific). It was further cloned in the pGEM-T Easy vector (Promega) and sequenced at Eurofins MWG Operon, Germany.

Sequence assembly {#s8}
-----------------

Sequence assembly (Clone Manager Professional 9, Sci-Ed software) was carried out using sequences obtained by inverse PCR and the *Pglpgip1p* sequence to determine the open reading frame (ORF) (*Pglpgip1*). Nucleotide BLAST searches were performed to ascertain the gene identity.

*Bioinformatic analysis of* Pglpgip1 {#s9}
------------------------------------

The deduced amino acid sequence of *Pglpgip1* (*Pgl*PGIP1) was further subjected to various *in silico* analyses using different bioinformatics tools: the signal peptide was identified using SignalP 4.1 ([@CIT0058]) and the targeted protein localization was predicted using WoLF PSORT ([@CIT0056]). The assignment of domains in *Pgl*PGIP1 was performed based on the NCBI conserved domain search analysis ([@CIT0049]) and on a comparative amino acid sequence alignment with *Pv*PGIP2 domain architecture ([@CIT0018]) using the T-Coffee tool ([@CIT0057]). The putative N-glycosylation sites were determined using NetNGly 1.0 (<http://www.cbs.dtu.dk/services/NetNGlyc/>).

The *Pgl*PGIP1 and other known monocot and dicot PGIP sequences (protein accession numbers are summarized in [Supplementary Table S1](http://jxb.oxfordjournals.org/lookup/suppl/doi:10.1093/jxb/eru266/-/DC1) at *JXB* online) from the National Center for Biotechnology Information database were aligned with MUSCLE version 3.7 ([@CIT0019]) and gaps and/or poorly aligned regions were removed with Gblocks version 0.91b ([@CIT0074]). A phylogenetic tree was generated using the maximum-likelihood method employed in PhyML version 3.0 aLRT ([@CIT0004]) on the <http://www.phylogeny.fr> platform ([@CIT0017]) using default settings. Internal branch consistency was appraised using the bootstrapping method with 100 bootstrap replicates. The tree was rendered using TreeDyn version 198.3 ([@CIT0011]).

The nucleotide sequence upstream of the ORF was submitted to PlantCARE ([@CIT0044]) to determine the presence of plant-specific *cis*-elements.

*Construction of the* Pgl*PGIP1 and* Fm*PGIII expression plasmids* {#s10}
------------------------------------------------------------------

The multistep cloning strategy involved in construction of the *Pgl*PGIP1 expression plasmid (pET-22b::MBP-IEGR-*Pgl*PGIP1-6×His-Strep-tag^®^ II, where IEGR is the factor Xa protease cleavage site and 6×His is a hexa-histidine tag) (construct E), vector control (pET-22b::MBP-IEGR-6×His-Strep-tag^®^ II) (construct F) and the *Fm*PGIII expression (pET-22b::*Fm*PGIII-Strep-tag^®^ II) (construct G) plasmids have been detailed in [Supplementary Table S2](http://jxb.oxfordjournals.org/lookup/suppl/doi:10.1093/jxb/eru266/-/DC1) at *JXB* online ([Supplementary Fig. S1](http://jxb.oxfordjournals.org/lookup/suppl/doi:10.1093/jxb/eru266/-/DC1) at *JXB* online provides a pictorial representation of the constructs). Briefly, the *Pglpgpip1* coding sequence was initially cloned in pET-22b(+) in frame with the vector-encoded 6×His sequence. Then, *malE* (MBP-encoding gene), followed by a factor Xa protease recognition site was cloned upstream of *pgip*, and a Strep-tag^®^ II-encoding sequence was cloned downstream of 6×His, allowing the synthesis of the fusion protein MBP--IEGR--*Pgl*PGIP1--6×His--Strep-tag^®^ II. The vector control was generated by eliminating the *pgip* sequence from construct E. *FmPGIII* was PCR amplified from the pGEMT-*FmPGIII* construct and subcloned upstream of the Strep-tag^®^ II in pET22b(+)-Strep-tag^®^ II, allowing the synthesis of the *Fm*PGIII--StrepII fusion protein. DNA manipulations such as agarose gel electrophoresis and bacterial transformation were carried out using standard protocols ([@CIT0063]). Restriction digestion (New England Biolabs), plasmid isolation (InnuPREP Plasmid Mini/Midi kit; Analytik Jena Biosciences), ligation (Rapid DNA Ligation kit; Thermo Scientific), and gel extraction (NucleoSpin^®^ Gel and PCR Clean-up kit; Macherey-Nagel) were carried out using kits according to the manufacturer's instructions.

*Production and purification of* Pgl*PGIP1 and* Fm*PGIII fusion proteins* {#s11}
-------------------------------------------------------------------------

Competent *E. coli* SHuffle^®^ T7 Express \[pLysSRARE2\] was transformed with the above-described constructs. Expression was carried out in 2 l batch cultures incubated for 24h at 26 °C using auto-induction solutions 'M' and '5052' as described by [@CIT0073]. The total protein was extracted by a freeze--thaw cycle inducing the lysozyme-mediated autolysis of the cells. Additionally, sonication on ice at 40% amplitude, three times for 1min each (10 s on/10 s off cycles) on a Branson Digital Sonifier 250-D (G. Heinemann Ultraschall- und Labortechnik, Germany) was performed. The soluble protein was obtained as supernatant by centrifugation of the cell lysate at 40,000 *g* for 30min at 4 °C.

All purification steps were carried out at 10 °C on a FPLC system (ÄKTAExplorer; GE Healthcare, Freiburg, Germany). A flow rate of 1ml min^--1^ was maintained throughout. The protein peaks were pooled appropriately after each purification step and concentrated using centrifugal concentrators (Vivaspin™20; Sartorius). The intermediate buffer exchanges and desalting steps were carried out using 5ml HiTrap columns (GE Healthcare).

The fusion protein MBP--IEGR--*Pgl*PGIP1--6×His--Strep-tag^®^ II (r*Pgl*PGIP1) was purified in two steps. In the first step, Strep-tag^®^ II-based affinity purification was performed on a 1ml Strep-Tactin Superflow Plus Cartridge (Qiagen) using 50mM NaH~2~PO~4~, 300mM NaCl (pH 8.0) as loading/wash buffer and loading buffer containing 2.5mM [d]{.smallcaps}-desthiobiotin (pH 8.0; IBA Lifesciences) as elution buffer according to the manufacturer's instructions. The desalted eluates were reconstituted in cation-exchange column loading/wash buffer (buffer A: 50mM NaH~2~PO~4~, pH 8.0) and subjected to purification on a 1ml RESOURCE Q Cartridge (GE Healthcare). The matrix-bound proteins were eluted (buffer B: 50mM NaH~2~PO~4~, 1M NaCl, pH 8.0) by applying a stepwise NaCl gradient \[0--22% (buffer A to B) in 15min, held for 2min; 22--24% in 5min, held for 2min; 24--28% in 5min, held for 2min; 28--100% in 20 min\] to resolve the desired protein from contaminating proteins. The r*Pgl*PGIP1 eluted at 22--24% NaCl held for 5min.

Recombinant *Fm*PGIII-Strep-tag^®^ II (r*Fm*PGIII) and the vector control MBP--IEGR--6×His--Strep-tag^®^ II (rVC) were purified by single-step affinity purification on a Strep-Tactin Superflow Plus Cartridge as described above.

Protein production and purification were monitored by immunoblot analysis of extracted proteins using Strep-Tactin^®^--horseradish peroxidase conjugate as probe (IBA Lifesciences). The chemiluminescence detection of blots was carried out as described previously ([@CIT0080]). The protein concentration of different samples was determined using a BCA protein assay kit (Pierce) with BSA as the standard.

PGIP activity assays {#s12}
--------------------

*An*PGII (5ng; kind gift from Mr Madhusudhan, University of Mysore, Mysore, India) and r*Fm*PGIII (36ng) were incubated separately in a reaction volume of 200 µl with 0.1mg ml^--1^ of polygalacturonic acid substrate (Sigma) at 30 °C in 50mM sodium acetate buffer (pH 4.2 and 4.6, respectively). PG activity was determined by reducing end-group analysis according to [@CIT0005]. PGIP activity was assayed by measuring the activity of the PGs pre-incubated with r*Pgl*PGIP1 for 20min at 30 °C. PGIP activity was expressed as the percentage reduction in the number of reducing ends (in µkat mg^--1^ of protein) liberated by PGs in the presence and absence of PGIP. rVC served as the control.

The effect of various parameters such as inhibitor concentration (0.316--12.64nM r*Pgl*PGIP1), substrate concentrations (0.025--0.25mg ml^--1^) and pH (3.5, 4.0, 4.5, and 5.0) on enzyme inhibition was determined. The kinetic parameters were computed by fitting the Michaelis--Menten equation on initial rate experimental data by non-linear fitting using OriginPro7 (Originlab). In separate experiments, the temperature and pH stability of r*Pgl*PGIP1 were studied by pre-incubating them separately for 1h at temperatures ranging from 20 to 100 °C, and for 16h at pH values of 2.0--11.0 at 4 °C, respectively, after which they were reconstituted in the appropriate assay buffer and their inhibition potential was assayed at 30 °C. All experiments were performed twice each in triplicate. The data of a representative experiment was subjected to Tukey's honestly significant difference (HSD) test following analysis of variance at *P*\<0.05.

*Homology modelling of* Pgl*PGIP1 and* Fm*PGIII* {#s13}
------------------------------------------------

The initial homology models of *Pgl*PGIP1 and *Fm*PGIII were generated using the MODELLER 9.12 package ([@CIT0022]), with the X-ray crystallographic structures of *Pv*PGIP2 \[Protein Data Bank identity (PDB ID): 1OGQ\] and endo-polygalacturonase I (*Fm*PGI) from *F. moniliforme* isolate FC-10 (PDB ID: 1HG8) serving as templates, respectively. The quality of the generated models was assessed using the Verify3D server ([@CIT0020]). Post-refinement of structural models was carried out using the KoBa^MIN^ server ([@CIT0062]), and further geometric accuracy of the constructed models was evaluated using MolProbity 4.02b ([@CIT0014]). The obtained models were further energy minimized using GROMACS 3.0 ([@CIT0046]) with a GROMOS96-53a6 force field to remove geometric inaccuracies and steric clashes with 1000 steepest descent steps terminated at the convergence of maximum force \<1000 kJ mol^--1^.

Electrostatic charge distribution analysis {#s14}
------------------------------------------

The adaptive Poisson--Boltzmann Solver program ([@CIT0077]) was employed to calculate the electrostatic distribution of the following individual proteins and complexes: *Pgl*PGIP1, *An*PGII, *Fm*PGIII, *Pgl*PGIP1--*An*PGII and *Pgl*PGIP1--*Fm*PGIII. PyMOL version 1.2r3pre (PyMOL Molecular Graphics System; Schrödinger, LLC) was used for the visualization of the surface representation.

Docking and energy minimization {#s15}
-------------------------------

To obtain accurate conformations of *Pgl*PGIP1--*An*PGII and *Pgl*PGIP1--*Fm*PGIII protein complexes, the docking simulation was carried out in two steps; in the first step, the protein pairs were subjected to GRAMM-X ([@CIT0076]) for the initial global search of conformation of the two proteins in complex form and subsequently, such output was resubmitted to the Rosetta 3.4 server ([@CIT0048]) for further optimization of docking results based on rigid body orientation and side-chain conformation. The three-dimensional structure of *An*PGII (PDB ID: 1CZF) used in the present docking study was retrieved from the PDB, Research Collaboratory for Structural Bioinformatics.

For energy minimization, molecular dynamics simulations at room temperature were carried out using GROMACS 3.0 ([@CIT0046]) with a GROMOS96-53a6 force field for bound *Pgl*PGIP1--*An*PGII and *Pgl*PGIP1--*Fm*PGIII complexes. Protein in complexed form was immersed in a cubic waterbox of space water model with box edges 1 Å from the complexed protein periphery. The overall electric charge of the system was compensated. The system was pre-equilibrated, which involved minimization using the steepest descent method. A molecular dynamics simulation was performed at constant volume and temperature for 1 ns. Snapshots were collected every 2 ps.

Protein--protein interaction map {#s16}
--------------------------------

Hydrogen bond, ionic, and hydrophobic interactions across protein--protein interfaces were determined by the Protein Interaction Calculator (PIC) server ([@CIT0075]). Interactions were visualized and analysed using molecular modelling programs PyMOL 1.6 and CHIMERA 1.8 ([@CIT0059]).

Computational mutagenesis {#s17}
-------------------------

Computational alanine-scanning mutagenesis was carried out using the Robetta alanine-scanning server ([@CIT0038]) in order to identify the energetically favourable amino acids at the interface that are important in the stability of the *Pgl*PGIP1--*An*PGII complex. This program scans the protein--protein interface for the 'hotspots' and evaluates the changes in the binding free energy of the complex by replacing each of the interface residue with alanine at the binding region.

The relative free energy of binding (ΔΔG~binding~) was calculated as follows:
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Positive values of ΔΔG~binding~ higher than 1 kcal mol^--1^ indicate that replacement by alanine is predicted to destabilize the complex.

Results and discussion {#s18}
======================

*Isolation of pearl millet* pgip *genes* {#s19}
----------------------------------------

Initially, two partial *pgip* sequences: *Pglpgip1p* (407bp, GenBank accession no. GU474543.1) and *Pglpgip2p* (497bp, GenBank accession no. JQ425039), which shared a nucleotide sequence identity of 84%, were isolated from pearl millet using primers based on the consensus sequence of known monocot *pgips*. PGIPs from the same plant, irrespective of whether they are of monocot or dicot origin, share significant identity ([@CIT0024]; [@CIT0027]; [@CIT0035]).

An inverse PCR approach was employed for the isolation of the complete *pgip* coding sequence. For this, a Southern blot analysis was performed to identify appropriate restriction endonucleases for template preparation. About 10 enzymes were tested; however, they did not or only partially cut the genomic pearl millet DNA. Only *Apo*I yielded a continuous digestion pattern and distinct hybridizing fragments of appropriate size ([Supplementary Fig. S2](http://jxb.oxfordjournals.org/lookup/suppl/doi:10.1093/jxb/eru266/-/DC1) at *JXB* online) and thus was selected to prepare the template. Of the two primer pairs used in the inverse PCR, only InvPGIP1A/InvPGIP1B amplified an intense fragment of \~2.0kb, which was further cloned and sequenced. The sequence assembly resulted in a 2295bp contig (GenBank accession no. JF421287) with an ORF of 1014bp (*Pglpgip1*) ([Supplementary Fig. S3](http://jxb.oxfordjournals.org/lookup/suppl/doi:10.1093/jxb/eru266/-/DC1) at *JXB* online). The pearl millet coding sequence was found to be uninterrupted, i.e. without any introns, upon comparison of the DNA and cDNA sequences. Most known PGIP-encoding genes have been shown to lack introns; however, exceptions do exist but only in case of dicots such as *Arabidopsis*, peach, raspberry and *Antirrhinum majus* ([@CIT0015]).

The Southern blot analysis of pearl millet genomic DNA and the isolation of two PGIP-encoding partial sequences indicated the possible occurrence of *pgip* in pearl millet as a small multigene family. However, further genome organization studies are necessary to confirm this. It has been reported that most plant *pgip* genes exist as small multigene families clustered within a specific chromosomal region ([@CIT0015]). *Brassica napus*, in contrast, is the only plant reported so far to contain a large gene family with at least 16 *pgips* ([@CIT0031]).

*Bioinformatic analysis of* Pglpgip1 {#s20}
------------------------------------

The bioinformatic characterization of *Pglpgip1* was carried out to understand the domain architecture of the deduced protein, its phylogenetic position among known PGIPs, and nature of *cis*-regulatory motifs upstream of the ORF. Only 130 (37%) amino acids were identical between *Pgl*PGIP1and *Pv*PGIP2; however, they were found to have a global alignment score of 95 ([Supplementary Fig. S4](http://jxb.oxfordjournals.org/lookup/suppl/doi:10.1093/jxb/eru266/-/DC1) at *JXB* online). A putative signal peptide of 27 aa was identified ([Fig. 1](#F1){ref-type="fig"}) for possible apoplastic localization (82% affirmative), which is crucial in plant defence against the invading microbial PGs encountered at the CW ([@CIT0018]). A central domain was detected in *Pgl*PGIP1, which contained 10 imperfect LRRs of an \~24 aa residue consensus sequence characteristic for PGIPs, xxLxLxx.NxLx..GxIPxxLxxL.xxL ([@CIT0018]). The pearl millet PGIP also contained two putative β-sheets, B1 and B2, and also the 3~10~-helix similar to *Pv*PGIP2. The central LRR domain has been shown in *Pv*PGIP2 to fold into a right-handed superhelix and is connected to the B1-sheet through loops or β-turns. The B2-sheet is a unique feature not found in other LRR proteins ([@CIT0018]). In *Pgl*PGIP1, the central domain was flanked by short N- and C- terminal regions with conserved C residues as reported for *Pv*PGIP2, known to be involved in disulfide linkages necessary for the structural integrity of the protein ([@CIT0018]). Seven putative *N*-glycosylation sites were predicted by NetNGly1.0 with a consensus sequence of N-x-S/T (where x is any amino acid except P), for *N*-glycosylation. Of the seven sites, positions 85 and 297 were conserved in all four rice PGIPs (*Os*PGIP1--4) and both wheat PGIPs reported previously ([@CIT0035]). N297 was the lone residue to be conserved even in *Pv*PGIP2, whose glycosylation positions have been experimentally mapped ([@CIT0051]). N288 was conserved in all rice and wheat PGIPs except in *Os*PGIP1. N258 was conserved in *Os*PGIP2 and *Os*PGIP3, whereas N177 was conserved only in the latter.

![Sequence organization of derived amino acid sequences of *Pgl*PGIP1. The displayed sequence organization is a result of alignment of *Pgl*PGIP1 with *Pv*PGIP2 whose secondary structure has been determined ([@CIT0018]). The LRR consensus sequence 'xxLxLxx.NxLx..GxIPxxLxxL.xxL' is shown. Putative residues contributing to form the secondary structure elements are based on *Pv*PGIP2 and indicated in light grey (sheets B1 and B2) and dark grey (3~10~-helix). Putative glycosylation sites are indicated by an asterisk. The conserved C residues are highlighted in black. Numbering of amino acid residues is shown on the left.](exbotj_eru266_f0001){#F1}

Phylogenetic analysis of the deduced protein, *Pgl*PGIP1, and other available monocot and dicot PGIP sequences using the maximum-likelihood approach clearly showed monocot and dicot PGIPs forming separate clusters ([Fig. 2](#F2){ref-type="fig"}). *Pgl*PGIP1, was placed among the monocot PGIPs but the millet PGIPs formed a separate branch. *Pgl*PGIP1 was found to share from 50% to just over 60% identity with most monocot PGIPs. The identity with dicots was, however, between 35 and 47%.

![Phylogenetic tree showing the affiliation of *Pgl*PGIP1 among other known monocot and dicot PGIPs. The deduced amino acid sequences of *Pgl*PGIP1 and other known PGIP sequences obtained from GenBank were aligned using MUSCLE version 3.7, curated using the Gblocks version 0.91b, and then submitted to PhyML version 3.0 aLRT for phylogenetic analysis, and the tree was rendered using TreeDyn version 198.3. The position of *Pgl*PGIP1 is highlighted by a box. The branch support values are represented at branch points and the branch length scale is shown below the tree. The protein accession numbers are summarized in [Supplementary Table S1](http://jxb.oxfordjournals.org/lookup/suppl/doi:10.1093/jxb/eru266/-/DC1).](exbotj_eru266_f0002){#F2}

Earlier evaluation of *cis*-regulatory elements of various plant *pgip* genes *in silico* detected elements responsive to light, wounding, salicylic acid, abscisic acid, fungal elicitors, ethylene, and various other motifs with unknown functions ([@CIT0042]; [@CIT0047]). The 1078bp sequence upstream of the *Pglpgip1* ORF was analysed *in silico* for the identification of *cis-*elements and showed the presence of numerous important regulatory motifs. The consensus motif sequences and their respective functions retrieved from PlantCARE have been summarized in [Supplementary Table S3](http://jxb.oxfordjournals.org/lookup/suppl/doi:10.1093/jxb/eru266/-/DC1) at *JXB* online ([Supplementary Fig. S5](http://jxb.oxfordjournals.org/lookup/suppl/doi:10.1093/jxb/eru266/-/DC1) at *JXB* online shows the position of the *cis*-elements in the upstream sequence). The presence of elements responsive to plant stress hormones (e.g. ACGT-containing abscisic acid response element, TC-rich repeats, TCA element, CGTCA motif, ethylene response elements) and anoxic stress (anaerobic response element) indicates a role for PGIP in pearl millet's response to biotic and abiotic stress. In bean cultivar 'Pinto', *PvPpgip2* was found to be upregulated in response to wounding, oligogalacturonides, glucan derived from *Phytophthora megasperma* f. sp. *glycinea* and salicylic acid ([@CIT0012]). A slightly higher accumulation of poplar *Pdpgip4* transcripts was observed over that of *Pdpgip2* transcripts at 1 and 4h after treatment with salicylic acid and H~2~O~2~, respectively ([@CIT0010]). However, similar expression levels were reported for both *pgip* genes in case of methyl jasmonate treatment. In Chinese cabbage, *pgip* expression levels were increased in response to abiotic stresses such as water-logging, salt, cold treatment, and mechanical wounding ([@CIT0003]). Significant numbers of elements were found to be responsive to light (e.g. Box 1, G-Box, Specificity protein 1). The effect of light on transcription as well as post-transcriptional processes in plant growth and development has been reported previously ([@CIT0029]). Plant defence genes have also been proposed to be circadian regulated, and biotic stress responses have been shown to be modulated by a light-sensing network in *Arabidopsis* ([@CIT0055]; [@CIT0028]; [@CIT0081]). A plant's ability to acclimatize to changes in quality and intensity of light has been found to be critical in mounting an effective response against invading pathogens ([@CIT0041]). Given the presence of numerous light-responsive elements in *Pglpgip1* and other known *pgips*, and the fact that *pgips* are known to be induced by both biotic and abiotic stresses, the relationship between light-induced *pgip* expression and plant defence makes perfect sense.

*Production of recombinant* Pgl*PGIP1 and* Fm*PGIII* {#s21}
----------------------------------------------------

r*Pgl*PGIP1 was produced in order to assess its potential inhibition against fungal PGs (r*Fm*PGIII and *An*PGII). Our initial attempts to synthesize these proteins in eukaryotic expression systems such as *Nicotiana benthamiana* and *Pichia pastoris* were not successful (data not shown). Furthermore, *Pgl*PGIP1 production in *E. coli* faced protein solubility and purification problems. Hence, several solubility and affinity purification fusion tags were tried out for the soluble production and purification of *Pgl*PGIP1 (data not shown). The N-terminal MBP and C-terminal Strep-tag^®^ II combination of solubility and affinity purification tags, respectively, were found to be optimal for its expression in *E. coli* SHuffle^®^ T7 Express (pLysSRARE2) and efficient purification. *Fm*PGIII expression faced no solubility issues, and hence only a C-terminal Strep-tag^®^ II was incorporated for purification purpose. Expression with pET-22b::MBP-IEGR-*Pgl*PGIP1-6×His-Strep-tag^®^ II in *E. coli* SHuffle^®^ T7 Express (pLysSRARE2) and purification of the resulting recombinant fusion protein by coupling an anion-exchange column downstream of Strep-Tactin Superflow Plus affinity matrix resulted in a homogenous pure protein, r*Pgl*PGIP1, of 79.1kDa ([Supplementary Fig. S6A](http://jxb.oxfordjournals.org/lookup/suppl/doi:10.1093/jxb/eru266/-/DC1) at *JXB* online). The two-step purification resulted in 505- and 1323-fold purification with protein recoveries of 37 and 33%, respectively.

The single-step affinity purification of r*Fm*PGIII and rVC on a Strep-Tactin Superflow Plus Cartridge resulted in relatively homogenous pure proteins of 37.9kDa ([Supplementary Fig. S6A](http://jxb.oxfordjournals.org/lookup/suppl/doi:10.1093/jxb/eru266/-/DC1)) and 46.3kDa ([Supplementary Fig. S6B](http://jxb.oxfordjournals.org/lookup/suppl/doi:10.1093/jxb/eru266/-/DC1)), respectively. Single-step purification of r*Fm*PGIII resulted in 320-fold enrichment with a protein recovery of 72%.

Immunoblot analysis confirmed the synthesis and successful purification of the recombinant proteins ([Supplementary Fig. S6](http://jxb.oxfordjournals.org/lookup/suppl/doi:10.1093/jxb/eru266/-/DC1)). In addition, tandem mass spectrometric analysis of trypsin-digested peptides of purified recombinant proteins was carried out. Subsequent correlation of the resulting spectral data using SEQUEST algorithm ([@CIT0021]) against a database containing information on theoretical digest of the respective fusion proteins confirmed their identity (data not shown).

In vitro *inhibition profile of r*Pgl*PGIP1* {#s22}
--------------------------------------------

The *in vitro* inhibition of r*Pgl*PGIP1 against *An*PGII and r*Fm*PGIII was carried out in order to compare it with the known inhibition profile of *Pv*PGIP2 against the same two PGs. Intact MBP--*Pgl*PGIP1 fusion protein was employed in the inhibition studies as protease factor Xa digestion for cleaving off MBP resulted in random degradation of protein (data not shown). r*Pgl*PGIP1 displayed a differential activity profile against the fungal PGs used in the present study, with only a partial inhibition observed against *An*PGII ([Fig. 3A](#F3){ref-type="fig"}) and no inhibition against r*Fm*PGIII. Hence, the effect of various parameters on *An*PGII inhibition by r*Pgl*PGIP1 has been presented below. The rVC, as expected, showed no inhibition of either enzyme. Possibly, the lack of glycosylation of r*Pgl*PGIP1 produced in *E. coli* could be a factor responsible for the limited inhibition observed.

![*An*PGII inhibition assay. (A) Effect of inhibitor concentration. *An*PGII (5ng) was assayed with and without inhibitor (r*Pgl*PGIP1/rVC) over a concentration range of 0.316--12.64nM and a graph with the enzyme activity over inhibitor concentration was plotted. (B) pH optimum. *An*PGII (5ng) was assayed with and without inhibitor at a concentration (r*Pgl*PGIP1/rVC) of 3.16nM and a graph with the enzyme activity over pH units was plotted to determine the pH optima of inhibition. (C) pH stability. *An*PGII (5ng) was assayed with and without inhibitor pre-incubated for 16h at pH values of 2.0--10.0 at 4 °C upon reconstitution in the assay buffer \[at a concentration (r*Pgl*PGIP1/rVC) of 3.16 nM\] and a graph with the enzyme activity over pH units was plotted to determine the pH stability of inhibitor. (D) Temperature stability. *An*PGII (5ng) was assayed with and without inhibitor pre-incubated for 1h at temperatures ranging from 20 to 100 °C \[at a concentration (r*Pgl*PGIP1/rVC) of 3.16 nM\] and a graph with the enzyme activity over temperature was plotted to determine the temperature stability of inhibitor. The data points are means of a single experiment carried out in triplicates. Results are shown as means±standard error. Means designated with the same letter are not significantly different according to Tukey's HSD test at *P*\<0.05.](exbotj_eru266_f0003){#F3}

*Pv*PGIP2 has been reported to competitively inhibit *Fm*PGI by binding at its substrate-binding site ([@CIT0043]), whereas *Fm*PGIII, which shares 91.7% amino acid identity with *Fm*PGI, evaded inhibition by the same PGIP ([@CIT0066]). Although a structural explanation is lacking, an attempt was made to explain the observed effect using amino acid sequence alignment. The chief difference between the *Fm*PGIII and *Fm*PGI consist of one short stretch of substitutions in the N-terminal region and ﬁve substitutions, two of which are close to the active site. These polymorphic sites may have led to subtle changes in the protein structure, thus preventing the accessibility of the substrate-binding site of *Fm*PGIII for interaction with *Pv*PGIP2 ([@CIT0066]). As mentioned earlier, although sharing 37% amino acid identity, the global alignment score of *Pgl*PGIP1 and *Pv*PGIP2 is very high due to the degeneracy of residues in the LRR domain. Hence, lack of potency of *Pgl*PGIP1 against *Fm*PGIII is understandable. Assessment of the *Pgl*PGIP1--*Fm*PGI interaction could further be useful for a deeper comparative profiling of inhibition with *Pv*PGIP2.

*Effect of inhibitor concentration on* An*PGII activity* {#s23}
--------------------------------------------------------

No inhibition was observed at the lowest r*Pgl*PGIP1 concentration tested, but a gradual increase in inhibition was observed with increasing inhibitor concentration ([Fig. 3A](#F3){ref-type="fig"}). A significant increase in inhibition was observed at r*Pgl*PGIP1 concentrations of 0.632, 1.26, and 3.16nM with inhibition being 7, 16, and 26%, respectively. However, a further increase of the r*Pgl*PGIP1 concentration (up to 6.32 and 12.64nM) resulted in marginally increased inhibition reaching a value of 28% at most. PGIP concentrations of 3.16nM and/or 1.26nM were used in further studies.

Although the pattern of inhibition of both r*Pgl*PGIP1 and *Pv*PGIP2 against the same two PGs was similar, bean PGIP showed complete inhibition against *An*PGII at concentrations lower than that used in the present study ([@CIT0043]; [@CIT0066]). As observed in the present study, such partial inhibitions of various PGs have been reported in several PG/PGIP systems ([@CIT0030]). PGIPs from cotton showed 50 and 25% inhibition against PGs from *Aspergillus niger* and *Verticillium dahlia*, respectively ([@CIT0032]). Wheat PGIP, on the other hand, showed just over 5% inhibition of PGs from *A. niger* and *F. moniliforme* ([@CIT0036]). PGIPs are very diverse in their inhibition specificity and potential, i.e. PGIPs isolated from a single plant can inhibit different PGs, the inhibitors isolated from different plants have been found to inhibit the same PG, some PGIPs have the ability to inhibit a multitude of PGs, and the degree of inhibition has also been found to vary greatly ([@CIT0030]). PGIPs have also been noted to have the potential to inhibit *in vitro* the PGs of those microbes that are non-pathogenic or to which they are generally not exposed, as in our case ([@CIT0030]). The presence of PGIPs with different inhibition potentials could be a ploy employed by the host ensuring the accumulation of elicitor-active oligogalacturonides.

*Mode of* An*PGII inhibition* {#s24}
-----------------------------

The control protein, rVC (1.26 and 3.16nM) had no effect on the kinetic parameters of *An*PGII ([Table 1](#T1){ref-type="table"}). r*Pgl*PGIP1 (1.26 and 3.16nM), however, was found to decrease the *V* ~max~ without affecting the *K* ~m~ of *An*PGII. Hence, the mode of inhibition was established to be non-competitive in nature. PGIPs depending on the PG are known to employ competitive, non-competitive, and mixed modes of inhibition, thus indicating that PGIPs are capable of recognizing different structural motifs in its various protein partners ([@CIT0069]). PGIPs from different sources have been shown to display similar as well as different inhibition kinetics against the same enzyme. For example, *Bc*PG from *Botrytis cineria* was competitively inhibited by pear PGIP but in a mixed mode by the inhibitor from bean ([@CIT0002]; [@CIT0069]). However, *An*PGII was non-competitively inhibited by PGIPs of tomato and bean ([@CIT0072]), as in our case.

###### 

The kinetic parameters of AnPGII with and without rVC and rPglPGIP1

*An*PGII (5ng) was assayed using a substrate concentration range of 0.025--0.25mg ml^--1^ with and without inhibitors (r*Pgl*PGIP1/rVC) at concentrations of 1.26 and 3.16nM. The kinetic parameters were calculated by fitting the Michaelis--Menten equation on initial rate experimental data by non-linear fitting using OriginPro 7 (Originlab).

                                  *K* ~*m*~ (mg ml^--1^)   *V* ~*max*~ (μkat mg^--1^ protein)
  ------------------------------- ------------------------ ------------------------------------
  *An*PGII                        0.091                    28.5
  *An*PGII+rVC (1.26nM)           0.091                    28.5
  *An*PGII+rVC (3.16nM)           0.092                    28.6
  *An*PGII+r*Pgl*PGIP1 (1.26nM)   0.092                    24.3
  *An*PGII+r*Pgl*PGIP1 (3.16nM)   0.091                    21.3

*pH optima of* An*PGII inhibition* {#s25}
----------------------------------

The *An*PGII inhibition by r*Pgl*PGIP1 (3.16nM) over a pH range of 3.5--5.0 showed the pH optima for inhibition to be between 4.0 and 4.5 with 25 and 22% inhibition, respectively ([Fig. 3B](#F3){ref-type="fig"}). However, no inhibition was observed at pH 3.5 and 5.0. The pH optima for inhibition of *A. niger* PG by PGIP-I and PGIP-II of guava fruit was determined to be 4.2, whereas that for PGIP-III was 4.4 when assayed over a pH range of 4.0--5.5 ([@CIT0016]). A study involving interaction of *Pv*PGIP2 with five isoforms of *A. niger* PGs (*An*PGI, *An*PGII, *An*PGA, *An*PGB, and *An*PGC) showed *Pv*PGIP2 to greatly reduce the activity of three of the PG isoforms---*An*PGI, *An*PGII and *An*PGB---at all tested pH values. For *An*PGA and *An*PGC, *Pv*PGIP2 displayed inhibition only at pH 4.75 and below pH 4.2, respectively. At pH 5.0, however, *Pv*PGIP2 was found to activate the two PG isoforms ([@CIT0037]). This diversity of PGIP activity in different pH environments is crucial in countering the multitude of PGs encountered from various pathogens with different pH optima. In addition, such differential PGIP activity has been proposed to be involved in mounting a better host defence response through the generation of a steady-state concentration of biologically active oligogalacturonides ([@CIT0037]).

*pH and thermal stability of r*Pgl*PGIP1* {#s26}
-----------------------------------------

r*Pgl*PGIP1 (at 3.16nM) was found to be stable over a wide range of pH values from 4.0 to 8.0 ([Fig. 3C](#F3){ref-type="fig"}). The inhibition potential decreased by approximately 50% at pH 3.0 and 9.0, with no observed inhibition at other tested pH values. Guava PGIPs were reported to be stable only over a narrow pH range of 2.0--4.0 ([@CIT0016]), but the PGIP from chilli retained \>50% activity at pH 3.0 and 8.0 ([@CIT0068]).

r*Pgl*PGIP1 (at 3.16nM) was found to be equally active from 20 to 50 °C ([Fig. 3D](#F3){ref-type="fig"}). The activity dropped very slightly to 22% at 60 °C and significantly at 70 and 80 °C to 11 and 3%, respectively. No inhibition was observed beyond this temperature. Earlier studies on thermal tolerance of the protein have shown it to be relatively thermostable. PGIPs from 'Bartlett' pear ([@CIT0001]) and orange ([@CIT0006]) retained significant activity at 60 °C. The latest study on PGIP isolated from tomato was found to retain partial inhibitory activity, even at 100 °C ([@CIT0064]).

In silico *analysis of* Pgl*PGIP1*--An*PGII and* Pgl*PGIP1*--Fm*PGIII complexes* {#s27}
--------------------------------------------------------------------------------

*In silico* protein modelling, docking, and computational mutagenesis studies were carried out to account for the differential behaviour of pearl millet PGIP against *An*PGII and *Fm*PGIII, and for the limited similarity in the inhibition of *Pgl*PGIP1 and *Pv*PGIP2 against the same two PGs. It was necessary to predict the underlying structural basis of interaction as the two PGIPs share an amino acid identity of just 37%.

*Homology modelling of* Pgl*PGIP1* and Fm*PGIII* {#s28}
------------------------------------------------

The initial homology models of *Pgl*PGIP1 ([Supplementary Fig. S7A](http://jxb.oxfordjournals.org/lookup/suppl/doi:10.1093/jxb/eru266/-/DC1) at *JXB* online) and *Fm*PGIII ([Supplementary Fig. S7B](http://jxb.oxfordjournals.org/lookup/suppl/doi:10.1093/jxb/eru266/-/DC1)) were generated using already known structures of *Pv*PGIP2 (PDB ID: 1OGQ) and *Fm*PGI (PDB ID: 1HG8) serving as templates, respectively. The quality of the models was assessed using Verify3D. Scores predicted for each residue of our constructed model were \>0.1, indicating that all of the residues were located in favourable structural environments. After post-refinement with the KoBa^MIN^ program, the final models were revalidated using MolProbity. In the present study, the MolProbity score for both the models was \>85%, representing a good quality model. Summarized results from KoBa^MIN^ and MolProbity are given in [Supplementary Table S4](http://jxb.oxfordjournals.org/lookup/suppl/doi:10.1093/jxb/eru266/-/DC1) at *JXB* online. Models further energy minimized using GROMOS96-53a6 force field to remove any local strains were finally used for the docking studies.

*Docking studies of* Pgl*PGIP1*--An*PGII and* Pgl*PGIP1*--Fm*PGIII complexes* {#s29}
-----------------------------------------------------------------------------

To predict the conformation and the putative interactions between *Pgl*PGIP1 with *An*PGII and *Fm*PGIII, two different protein--protein docking programs, GRAMM-X and Rosetta 3.4, were used. Firstly, using GRAMM-X, fast-Fourier-transformation-based unrestrained rigid body docking was performed, which generated the top 10 solutions of the complexes. In the absence of the detailed data on the binding mode or mutational studies on *Pgl*PGIP1, we selected the docked complex based on the present *in vitro* inhibition studies, as well as available experimental evidence from *Pv*PGIP2 interactions with the two enzymes ([@CIT0043]; [@CIT0025]; [@CIT0039]; [@CIT0018]; [@CIT0066]; [@CIT0052]; [@CIT0007]). For further optimization, selected models from GRAMM-X were subjected to Rosetta 3.4. This docking algorithm searches a set of conformations from a given starting conformation for the optimal fit between the two partners. It employs a Monte Carlo search followed by simultaneous optimization of side-chain conformations. The resulting 'decoys' obtained from the docking simulations were ranked using an energy function dominated by van der Waals interactions, an implicit solvation model and an orientation-dependent hydrogen bonding potential. Selection of the best docked conformation obtained from Rosetta 3.4 was based on: (i) docking score being an overall measure of the energy of the complex; (ii) an interface score representing the score of the complex minus the total score of each partner in isolation; and (iii) involvement of any residues in the interaction evident from the experimental studies from *Pv*PGIP2. The best docked conformations of the *Pgl*PGIP1--*An*PGII and *Pgl*PGIP1--*Fm*PGIII complexes are shown in [Fig. 4](#F4){ref-type="fig"}, and the docking and interface scores are presented in [Supplementary Table S5](http://jxb.oxfordjournals.org/lookup/suppl/doi:10.1093/jxb/eru266/-/DC1) at *JXB* online.

![Protein docking analysis. Docked poses of *Pgl*PGIP1--*An*PGII (A) and *Pgl*PGIP1--*Fm*PGIII (B) complexes. *Pgl*PGIP1 interacts through its solvent-exposed concave cavity with *An*PGII and *Fm*PGIII at their N- and C-termini (circled in black), respectively. The substrate-binding site in *Fm*PGIII appears to be more exposed compared with that of *An*PGII. (This figure is available in colour at *JXB* online.)](exbotj_eru266_f0004){#F4}

From the docked protein complexes, it was suggested that *An*PGII ([Fig. 4A](#F4){ref-type="fig"}) and *Fm*PGIII ([Fig. 4B](#F4){ref-type="fig"}) both interact with *Pgl*PGIP1 at its concave surface, but their binding orientations differ. The residues at the β-strand/β-turn motif of the central LRR domain constitute the solvent-exposed concave surface of the PGIP and this region determines the binding specificity for PGs ([@CIT0040]). LRRs are known to be versatile protein recognition domains present in over 14,000 proteins ([@CIT0050]). In case of the *Pgl*PGIP1--*An*PGII complex, the concave site of *Pgl*PGIP1 interacts with the N-terminal site of *An*PGII, whereas in the *Pgl*PGIP1--*Fm*PGIII complex, the concave site of *Pgl*PGIP1 interacts with the C-terminal site of *Fm*PGIII. The substrate-binding site in *Fm*PGIII appeared to be more exposed compared with that of *An*PGII. In terms of the docking score, binding of *Pgl*PGIP1 with *An*PGII was predicted to be stronger in comparison with *Fm*PGIII. These *in silico* results are consistent with the *in vitro* outcomes. Interaction of *Pv*PGIP2 with *An*PGII and *Fm*PGI showed some residues important for interaction with one PG to be dispensable for interaction with the other, suggesting that different but overlapping subsets of residues are vital in binding different ligands ([@CIT0043]). The molecular docking simulation of the *Bc*PG1--*Pv*PGIP2 complex showed the B1-sheet of *Pv*PGIP2 to interact with the N-terminus of *Bc*PG1, and the active site of *Bc*PG1 was partially buried by the *Pv*PGIP2 C-terminus ([@CIT0069]). Analysis of the *Pv*PGIP2--*Fm*PG1 (now referred to as *Fp*PG) complex showed the residues present at both the convex and concave side of the PGIP N-terminus to be involved in interaction with the loops surrounding the active site of the PG ([@CIT0007]). These studies further demonstrated the structural flexibility and the versatility of PGIP binding interactions with the various PGs.

*Evaluation of protein--protein interactions in* Pgl*PGIP1*--An*PGII and* Pgl*PGIP1*--Fm*PGIII complexes by PIC analysis* {#s30}
-------------------------------------------------------------------------------------------------------------------------

Energy-minimized *Pgl*PGIP1--*An*PGII and *Pgl*PGIP1--*Fm*PGIII complexes were analysed using the PIC server to predict all possible types of interactions at the protein--protein interfaces, and the putative amino acid residues involved were mapped ([Table 2](#T2){ref-type="table"}). It was apparent from the data that the protein--protein contacts in both complexes were mediated through all types of interactions, i.e. ionic, hydrophobic, and hydrogen bonds, whereas the ionic and hydrophobic interactions were predominating at the surface. However, in the docked as well as energy-minimized structures, the *Pgl*PGIP1--*An*PGII complex was found to have a stronger binding interaction than that recorded in the *Pgl*PGIP1--*Fm*PGIII complex.

###### 

Protein interaction analysis of PglPGIP1--AnPGII and PglPGIP1--FmPGIII complexes using the PIC

The residue pairs involved in the interacting complexes, sorted according to the type of interaction, are shown (the PGIP residue numbering followed excludes the putative signal peptide).

  Hydrophobic interactions                              
  ----------------------------------- ---------- ------ ------
  F54                                 Y130       W105   A306
  M100                                W85        W243   I332
  I102                                W85        L268   A330
  W105                                A43               
  F124                                P56               
  F129                                A40               
  A172                                P56               
  V175                                A36               
  Side-chain H-bonding interactions                     
  T28                                 S234       R153   N266
  H79                                 T64        D222   T332
  N145, N147                          E83               
  S195                                E54               
  Q219                                E54               
  Ionic interactions                                    
  D31                                 R233       D56    K269
  D42                                 K124       D290   K300
  D50                                 K127              
  R74                                 E83, E84          
  L77                                 D62               
  H79                                 D62               
  D126                                K39               
  R240                                E54               

*Electrostatic surface charge distribution on* Pgl*PGIP1*, An*PGII, and* Fm*PGIII individually, and the* Pgl*PGIP1*--An*PGII and* Pgl*PGIP1*--Fm*PGIII complexes* {#s31}
-----------------------------------------------------------------------------------------------------------------------------------------------------------------

To illustrate the charge distributions of molecules, a three-dimensional electrostatic surface potential was generated separately on *Pgl*PGIP1 ([Fig. 5A](#F5){ref-type="fig"}), *An*PGII ([Fig. 5B](#F5){ref-type="fig"}), and *Fm*PGIII ([Fig. 5C](#F5){ref-type="fig"}), as well as on the *Pgl*PGIP1--*An*PGII ([Fig. 5D](#F5){ref-type="fig"}) and *Pgl*PGIP1--*Fm*PGIII ([Fig. 5E](#F5){ref-type="fig"}) complexes.

![Electrostatic surface potential of individual proteins and protein complexes. Electrostatic potential maps of *Pgl*PGIP1 (A), *An*PGII (B), *Fm*PGIII (C), *Pgl*PGIP1--*An*PGII (D), and *Pgl*PGIP1--*Fm*PGIII (E) complexes on which surface colours are fixed at red (--5) or blue (+5). Marked regions display the difference in charge distributions in surface maps of the individual proteins.](exbotj_eru266_f0005){#F5}

The surface comparison of *An*PGII and *Fm*PGIII suggested that the structures not only differed with respect to charge distribution but also differed in shape. This difference in the surface potential of the individual enzymes was also reflected in their predicted differential binding interactions with *Pgl*PGIP1. Once again, the *Pgl*PGIP1--*An*PGII complex was more compact than *Pgl*PGIP1--*Fm*PGIII, with the active site cleft of *Fm*PGIII exposed to a greater extent, which further explicated the *in vitro* results. This is consistent with an earlier report that electrostatic and van der Waals interactions play a significant role in the proper recognition and discrimination of PGs by PGIPs ([@CIT0052]).

*Analysis of* Pgl*PGIP1*--An*PGII interaction by computational alanine-scanning mutagenesis* {#s32}
--------------------------------------------------------------------------------------------

The residues at the β-strand/β-turn motif of *Pv*PGIP2 have been shown to interact with *An*PGII at the D110 α-helix, opposite the substrate-binding site, which fits perfectly with the non-competitive mode of inhibition ([@CIT0072]). To identify the hotspot residues involved in the interaction of *Pgl*PGIP1 and *An*PGII, which also follows the non-competitive mode of inhibition, a computative alanine mutagenesis of residues at the interface was carried out. Virtual scanning was performed over all interface residues and changes in the binding free energy were calculated upon alanine substitution of residues at protein--protein interfaces.

From the existing experimental data on *Pv*PGIP2, the amino acids H104, Y105, Y107, D131, V152, F201, Q224, and K225 have been reported to be important in interaction with *An*PGII ([@CIT0043]; [@CIT0009]; [@CIT0071]; [@CIT0007]). Alignment of *Pv*PGIP2 and *Pgl*PGIP1 sequences identified *Pgl*PGIP1 residues T99, M100, I102, D126, N147, Q196, Q219, and I220, respectively, at positions corresponding to the *Pv*PGIP2 residues mentioned above. Interestingly, computational mutagenesis predicted six of them to be hotspot residues significantly involved in interaction, except for I102 and I220, with ΔΔG~binding~ values of 0.61 and 0.87 kcal mol^--1^, respectively ([Fig. 6A](#F6){ref-type="fig"}). In addition, all the identified residues could be pinned down to the β-strand/β-turn solvent-exposed region except for D31, N145, and R240 found localized at the N-terminus, LRR-4 and LRR-8 in the central domain ([Fig. 1](#F1){ref-type="fig"}), respectively.

![Computational alanine mutagenesis of *Pgl*PGIP1--*An*PGII interface residues. The plot displays the contribution of individual interacting residues from *Pgl*PGIP1 (the PGIP residue numbering followed excludes the putative signal peptide) (A) and *An*PGII (B) in the stability of the *Pgl*PGIP1--*An*PGII complex. Interface residues were defined as those residues with a side chain having at least one atom within a sphere with 4 Å radius of an atom belonging to the other partner in the complex and binding hotspots defined as those residues that show ∆∆G~binding~ \>1 kcal mol^--1^.](exbotj_eru266_f0006){#F6}

The information on *An*PGII residues involved in interaction with PGIPs is very limited. Studies on conformational changes in *An*PGII--HG--*Pv*PGIP2 using amide-exchange mass spectrometry identified four residues (E95, G104, D110, and I139) to be involved in *Pv*PGIP2 binding ([@CIT0039]). The residues were found to lie opposite the substrate-binding site around the underside of the barrel near the D110 α-helix, consistent with the reported non-competitive mode of inhibition. However, the docking pose and protein--protein interaction analysis as well as the computational alanine-scanning mutagenesis of the *Pgl*PGIP1--*An*PGII complex ([Fig. 6A](#F6){ref-type="fig"}, [B](#F6){ref-type="fig"}) identified that the N-terminal region of *An*PGII interacts with the concave surface of *Pgl*PGIP1. Many of the identified residues were found to be localized mainly at the small α-helix, and β-strands of β-sheet PB1 at the N-terminus of *An*PGII away from the substrate-binding surface, which again is consistent with the observed non-competitive mode of inhibition.

Most residues of *Pgl*PGIP1 and *An*PGII identified by protein--protein interaction analysis as involved in interaction were also identified as significantly important upon computational alanine-scanning mutagenesis ([Table 2](#T2){ref-type="table"} and [Fig. 6](#F6){ref-type="fig"}). The D126 (*Pgl*PGIP1)--K39 (*An*PGII) interaction was predicted by alanine mutation studies to be the most significant binding contact in the *Pgl*PGIP1--*An*PGII complex.

The above results predicted the preferential use of very similar motif regions in PG recognition by the two PGIPs with few identical amino acids. *Pv*PGIP2 shares 99 and 88% identity with *Pv*PGIP1 and *Gm*PGIP3, respectively, at the amino acid level. However, assessment of their inhibition against *An*PGII and *Fm*PGI, unexpectedly showed *Pv*PGIP2 and *Gm*PGIP3 to share similar inhibition profiles, but *Pv*PGIP2 and *Pv*PGIP1 did not ([@CIT0043]; [@CIT0013]). Docking studies of these complexes proposed that not just sequence similarity but also conservation of key structural features are crucial in preserving the function mediated by appropriate protein---protein interactions ([@CIT0052]). Even though *Pgl*PGIP1 and *Pv*PGIP2 employed similar motifs for interaction with *An*PGII at non-substrate-binding sites, they engaged different regions of *An*PGII. Subtle differences in the overlapping residues as well as recruitment of additional, completely different amino acids could be responsible for the observed binding disparity.

*In silico* alanine mutation studies predicted D126 (*Pgl*PGIP1)--K39 (*An*PGII) interaction as the single most important binding contact in the *Pgl*PGIP1--*An*PGII complex. This could be important as the D126 position is an evolutionarily conserved residue in PGIPs. The importance of a single amino acid in protein--protein interaction has been observed earlier. *Pv*PGIP1 gained the ability to inhibit *Fm*PGI through a single amino acid substitution of K224 into the corresponding amino acid of *Pv*PGIP2, a Q ([@CIT0043]). Hence, *in silico* analysis of the *Pgl*PGIP1--*An*PGII complex is a good starting point for further experimental mutational analysis to arrive at the actual residues involved in protein--protein interactions.

In conclusion, the present study, together with earlier literature, suggests that the PG--PGIP interactions are complex, and structural and mutational analyses of various PG--PGIP complexes would be needed before a comprehensive generalized conclusion could be drawn about structure--function correlation. Pearl millet is afflicted by many fungal and bacterial diseases. Downy mildew disease alone accounts for annual production losses in the range of 20--40% ([@CIT0070]). Such protein--protein interaction studies will be crucial from the perspective of generation of designer host proteins with improved combat potential against the ever-evolving pathogen virulence factors.

Supplementary data {#s33}
==================

Supplementary data are available at *JXB* online.

[Supplementary Table S1](http://jxb.oxfordjournals.org/lookup/suppl/doi:10.1093/jxb/eru266/-/DC1). List of plant PGIPs used in the protein phylogenetic analysis.

[Supplementary Table S2](http://jxb.oxfordjournals.org/lookup/suppl/doi:10.1093/jxb/eru266/-/DC1). Construction of *Pgl*PGIP1, vector control and *Fm*PGIII expression plasmids for expression in *Escherichia coli* SHuffle^®^ T7 Express (pLysSRARE2).

[Supplementary Table S3](http://jxb.oxfordjournals.org/lookup/suppl/doi:10.1093/jxb/eru266/-/DC1). Upstream sequence analysis of the *Pglpgip1* gene.

[Supplementary Table S4](http://jxb.oxfordjournals.org/lookup/suppl/doi:10.1093/jxb/eru266/-/DC1). Refinement of *Pgl*PGIP1 and *Fm*PGIII models.

[Supplementary Table S5](http://jxb.oxfordjournals.org/lookup/suppl/doi:10.1093/jxb/eru266/-/DC1). Docking and interface scores of *Pgl*PGIP1--*An*PGII and *Pgl*PGIP1--*Fm*PGIII complexes.

[Supplementary Fig. S1](http://jxb.oxfordjournals.org/lookup/suppl/doi:10.1093/jxb/eru266/-/DC1). Pictorial representation of the *Pgl*PGIP1, vector control and *Fm*PGIII expression plasmids for expression in *Escherichia coli* SHuffle^®^ T7 Express (pLysSRARE2).
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HG
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:   leucine-rich repeat
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ORF
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